Home
Science
About
News
Careers
More
RiboX focuses on the discovery and development of fully engineered circular RNA therapeutics - a new class of RNA medicines which can overcome current limitations of mRNA therapeutics and realize the full potential of RNA medicines.
Dr. Weiyi Zhang
Chief Executive Officer
Dr. Yizhen Xu
Chief Medical Officer
Dr. Jennifer Kang
Head of IP & Corporate Legal